SMTL ID : 5brn.1

Human HGPRT in complex with (S)-HPEPHx, an acyclic nucleoside phosphonate

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-tetramer

Ligands

4 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: E.134, D.135 Ligands: 4X2.2 5 PLIP interactions: 2 interactions with chain A, 3 Ligand-Water interactions Metal complexes: A:E.134, A:D.135, H2O.2, H2O.2, H2O.3 MG.3: 3 residues within 4Å: Chain B: E.134, D.135 Ligands: 4X2.4 5 PLIP interactions: 2 interactions with chain B, 3 Ligand-Water interactions Metal complexes: B:E.134, B:D.135, H2O.4, H2O.4, H2O.5 MG.5: 3 residues within 4Å: Chain C: E.134, D.135 Ligands: 4X2.6 5 PLIP interactions: 2 interactions with chain C, 3 Ligand-Water interactions Metal complexes: C:E.134, C:D.135, H2O.6, H2O.8, H2O.8 MG.7: 3 residues within 4Å: Chain D: E.134, D.135 Ligands: 4X2.8 5 PLIP interactions: 3 interactions with chain D, 2 Ligand-Water interactions Metal complexes: D:E.134, D:E.134, D:D.135, H2O.8, H2O.10

4 x 4X2: (2-{[(2S)-1-hydroxy-3-(6-oxo-1,6-dihydro-9H-purin-9-yl)propan-2-yl]oxy}ethyl)phosphonic acid(Non-covalent)

4X2.2: 13 residues within 4Å: Chain A: I.136, I.137, D.138, T.139, G.140, K.141, T.142, K.166, K.186, F.187, V.188, D.194 Ligands: MG.1 14 PLIP interactions: 14 interactions with chain A Hydrogen bonds: A:D.138, A:T.139, A:T.139, A:T.139, A:G.140, A:K.141, A:T.142, A:T.142, A:K.166, A:V.188, A:V.188 Water bridges: A:K.141, A:M.143 pi-Stacking: A:F.187 4X2.4: 13 residues within 4Å: Chain B: D.135, I.136, D.138, T.139, G.140, K.141, T.142, K.166, K.186, F.187, V.188, D.194 Ligands: MG.3 14 PLIP interactions: 14 interactions with chain B Hydrogen bonds: B:D.135, B:D.138, B:D.138, B:T.139, B:T.139, B:T.139, B:G.140, B:K.141, B:T.142, B:K.166, B:V.188, B:V.188 Water bridges: B:R.200 pi-Stacking: B:F.187 4X2.6: 13 residues within 4Å: Chain C: D.135, I.136, I.137, D.138, T.139, G.140, K.141, T.142, K.166, F.187, V.188, D.194 Ligands: MG.5 15 PLIP interactions: 15 interactions with chain C Hydrogen bonds: C:D.138, C:D.138, C:T.139, C:T.139, C:T.139, C:G.140, C:K.141, C:T.142, C:K.166, C:V.188, C:V.188 Water bridges: C:I.136, C:M.143, C:R.170 pi-Stacking: C:F.187 4X2.8: 14 residues within 4Å: Chain D: D.135, I.136, I.137, D.138, T.139, G.140, K.141, T.142, K.166, K.186, F.187, V.188, D.194 Ligands: MG.7 15 PLIP interactions: 15 interactions with chain D Hydrogen bonds: D:D.135, D:D.138, D:D.138, D:T.139, D:T.139, D:T.139, D:G.140, D:K.141, D:T.142, D:T.142, D:K.166, D:V.188, D:V.188 Water bridges: D:G.70, D:M.143

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kaiser, M.M. et al., Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases. Chemmedchem (2015)

Release Date

2015-10-14

Peptides

Hypoxanthine-guanine phosphoribosyltransferase: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

Hypoxanthine-guanine phosphoribosyltransferase

Related Entries With Identical Sequence